SB 5519 (see companion bill HB 1508) – WashingtonStatus: In Process
Year Introduced: 2023
Adds penalties to cost growth benchmark implementation. The Transparency Board may use information received from existing data sources, such as the Washington Health Benefit Exchange and the Prescription Drug Affordability Board. The Transparency Board may share its data with the Prescription Drug Affordability Board and other health care cost analysis efforts. In addition, the Transparency Board may collect necessary data from payers and health care providers and levy civil fines on those who violate data submission requirements. The Health Care Authority (Authority) is expressly authorized to conduct activities to support the Transparency Board, including activities related to data collection and analysis, the enforcement of performance improvement plan submissions, and the payment of fees and fines. The Transparency Board may levy civil fines on payers and health care providers that violate its data submission requirements, including failing to submit data, submitting data late, and submitting inaccurate data.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.